Showing results (601-610 of 1,030) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|May 10, 2017
Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trialPatricia van Velzen, Gerben Ter Riet, Paul Bresser, et al.
The Lancet. Respiratory Medicine|July 9, 2017
The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entityDaniele De Luca, Anton H van Kaam, David G Tingay, et al.
The Lancet. Respiratory Medicine|May 27, 2017
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trialGary T Ferguson, J Mark FitzGerald, Eugene R Bleecker, et al.
The Lancet. Respiratory Medicine|April 14, 2018
Normothermic ex-vivo preservation with the portable Organ Care System Lung device for bilateral lung transplantation (INSPIRE): a randomised, open-label, non-inferiority, phase 3 studyGregor Warnecke, Dirk Van Raemdonck, Michael A Smith, et al.
The Lancet. Respiratory Medicine|April 11, 2018
Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trialTimo Vesikari, Judith Kirstein, Grace Devota Go, et al.
The Lancet. Respiratory Medicine|July 3, 2017
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohortMeiLan K Han, Pedro M Quibrera, Elizabeth E Carretta, et al.
The Lancet. Respiratory Medicine|December 11, 2013
Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trialAlberto Papi, Massimo Corradi, Catherine Pigeon-Francisco, et al.
The Lancet. Respiratory Medicine|December 11, 2013
GOLD 2011 disease severity classification in COPDGene: a prospective cohort studyMeiLan K Han, Hana Muellerova, Douglas Curran-Everett, et al.
The Lancet. Respiratory Medicine|November 10, 2016
Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trialKiyotaka Yoh, Takashi Seto, Miyako Satouchi, et al.
The Lancet. Respiratory Medicine|April 15, 2014
Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control studyCarla Magda Allan S Domingues, Jennifer R Verani, Ernesto Issac Montenegro Renoiner, et al.
Pageof 103